期刊文献+

多发性硬化树突状细胞分泌细胞因子的检测与意义 被引量:1

下载PDF
导出
摘要 目的:检测多发性硬化(MS)患者树突状细胞(DC)分泌的细胞因子,探讨DC及其分泌的细胞因子在MS发病机制中的作用。方法:利用MS患者外周血单核细胞培养诱导成为成熟DC,用人IL-12、IL-23、IL-27和人TNF-α的ELISA试剂盒检测DC分泌的细胞因子,并与正常对照组比较。结果:MS来源的DC分泌的IL-12、IL-23和TNF-α较对照组增多,差异有统计学意义;IL-27在两组DC分泌的量无明显差异。结论:IL-12、IL-23和TNF-α与MS的发病有关,未发现IL-27与MS发病的关系。
出处 《实用医学杂志》 CAS 北大核心 2011年第2期218-220,共3页 The Journal of Practical Medicine
基金 广西科学基金项目(编号:桂科回0991009) 广西卫生厅自筹经费科研课题(编号:Z2009097)
  • 相关文献

参考文献10

  • 1Compston A,Coles A. Muhiple sclerosis [J]. Lancet, 2008, 372(9648) : 1502-1517.
  • 2于周,李作孝.CD4+CD25+调节性T细胞、Foxp3与多发性硬化的关联[J].中华神经医学杂志,2009,8(1):98-100. 被引量:3
  • 3游文霞,陆正齐,胡学强,吕科峰,邹艳,朱灿胜.视神经脊髓炎与多发性硬化的临床症状、脊髓MRI表现的对比分析[J].中华神经医学杂志,2009,8(3):291-294. 被引量:3
  • 4Wiesemann E, Deb M, Trebst C, et al. Effects of interferon- beta on co-signaling molecules: upregulation of CD40,CD86 and PD-L2 on monoeytes in relation to clinical response to interferon-beta treatment in patients with multiple selero sis [J].Mult Scler, 2008,14(2): 166-176.
  • 5罗秋云,许南燕,邹琼辉.多发性硬化患者血清TNF-α、IFN-γ、IL-10检测及临床意义[J].实用临床医学(江西),2008,9(3):10-11. 被引量:4
  • 6Elena F, Ehud H, Kerstin M, et al. SPPL2a and SPPL2b promote intramembrane proteolysis of TNF [alpha} in activated dendritic cells to trigger IL-12 produe Lion [J]. Na Cell Biology, 2006,8 (8) : 843-848.
  • 7Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes imnm-ne inflammation through TH1 cell differentiation and TH17 cell expansion [J]. Nat Medicine, 2009,15 (6) : 633-640.
  • 8Cua D J,Sherlock J, Chen Y,el al. lnterteukin-23 rather than interleukin-12 is the critical eytokine for autoimmune inflammation of the brain[J].Nature, 2003,421(6924) : 744- 748.
  • 9Li Y, Chu N, Hu A, et al. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia [J]. Brain, 2007,130(2) :490-501.
  • 10Mellergard J, Edstrom M, Vrethem M, et al. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid [J]. Multiple Sclerosis, 2010, 16(2) :208-217.

二级参考文献26

  • 1Huanfa Yi,Yu Zhen,Lingling Jiang,Jialin Zheng,Yong Zhao.The Phenotypic Characterization of Naturally Occurring Regulatory CD4^+CD25^+T Cells[J].Cellular & Molecular Immunology,2006,3(3):189-195. 被引量:31
  • 2戴茹娟,王嗣欣.细胞因子与多发性硬化[J].国外医学(神经病学.神经外科学分册),1996,23(5):225-227. 被引量:2
  • 3Lennon VA, Wingerchuk DM, Kryzer T J, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis[J]. Lancet, 2004, 364(9451): 2106-2112.
  • 4Lennon VA, Kryzer TJ, Pittock S J, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel[J]. J Exp Med, 2005, 202(4): 473-477.
  • 5Cross SA. Rethinking Neuromyelitis Optica (Devic Disease) [J]. J NeuroOphthalmol, 2007, 27(1): 57-60.
  • 6Weinshenker BG, Wingerchuk DM. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker [J]. Curr Top Microbiol Immunol, 2008, 318: 343-356.
  • 7Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"[J]. Ann Neurol. 2005, 58(6): 840-846.
  • 8Wingerchuk DM, Lennon VA, Pittock S J, et al. Rivised diagnostic criteria for neuromyelitis optica [J]. Neurology, 2006, 66 (10): 1466-1467.
  • 9Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course ofneuromyelitis optica (Devie's syndrome)[J]. Neurology, 1999, 53(5): 1107-1114.
  • 10Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis [J]. Brain, 2007, 130(Pt 5): 1224-1234.

共引文献7

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部